the state launched a review into the newspaper�s findings in late april.
.imagine a congressional hearing held before media cameras, with reporters all over the us and europe ready with shocking articles about one of the leading causes of death�
.
.
.
.
.
'indian ip and liabilities law barrier to pharma r&d investment'